References
- Lacey R W, Lord V L, Howson GL. In vitro evaluation of miocamycin: bactericidal activity against streptococci. J Antimicrob Chemother 1984; 13: 5–13
- Soussy C J, Leclercq R, Duval J. In vitro antibacterial activity of a new macrolide: miocamycin. Comparison with erythromycin and josamycin. Pathol Biol (Paris) 1988; 36: 370–6
- Ridgway G L, Mumtaz G, Gabriel G, Oriel JD. The activity of miocamycin (MOM) against Chlamydia trachomatis and mycoplasmas in vitro. J Antimicrob Chemother 1983; 12: 511–4
- Olivi O. Efficacy and tolerance of miocamycin, a new macrolide, in paediatrics. 14th I.C.C., Kyoto, 1985, Abst. S35–9
- Catalano GB. Miocamycin for the management of otorhinolaryngological infections. 14th I.C.C., Kyoto, 1985, Abst. S35–14
- Fraschini F, Scaglione F, Cantarella G. Plasma and tissue concentrations of miocamycin in humans. Recent advances in chemotherapy, J Ishigami. University of Tokyo Press, Tokyo 1985; 1447–9
- Fraschini F, Scaglione F, Cantarella G, Marchi E, Scarpazza P. Farmacocinetica e diffusione tissutale della miocamicina. Annali Istituto Superiore Sanita 1987; 23: 887–90
- Tos M. Pathologie und Pathogenese der chronischen sekretorischen Otitis im Kindesalter. HNO 1976; 24: 37–47
- Sundberg L, Eden T, Ernstson S, Pahlitzsch R. Penetration of erythromycin through respiratory mucosa. Acta Otolaryngol (Stockh) 1979; 1–17, Suppl 365
- Förster D, Dedden H, Grimm H, Rost H, Wiedemann B, Zembrod A. Computer-assisted reading system for microbiological test. Rapid methods and automation in microbiology and immunology, KO Habermehl. Springer Verlag, Berlin 1984; 580–8
- Sundberg L, Eden T, Ernstson S. The penetration of erythromycin into the middle ear. Infection 1982; 10: 102–4, Suppl 2
- Varotto F, Garlaschi M L, Garlaschi MC. In vitro postantibiotic effect (PAE) of miocamycin and erythromycin on Gram-positive cocci. J Chemother 1990; 2: 355–61
- Bass J W, Steele R W, Wiebe R A, Dierdorff EP. Erythromycin concentrations in middle ear exudates. Pediatrics 1971; 48: 417–22
- Kitahara M. Management of upper respiratory tract infection in Japan. Scand J Infect Dis 1988; 20–3, Suppl. 57
- Sugita R, Ichikawa G, Goto S. A bacterial investigation of acute purulent otitis media. Nippon Jibiinkoka Gakkai Kaiho 1979; 82: 568–73
- Sugita R, Kawamura S, Ichikawa G. Chemotherapy of acute purulent otitis media. Nippon Jibiinokoka Gakkai Kaiho 1979; 82: 1381–7
- Alesina R, Colombo M L, Ferrara A, Gialdroni-Grassi G. Attivita antibatterica in vitro della miocamicina. Chemioterapia Antimicrobica 1981; 4: 341–50
- Yoshida T, Watanabe T, Shomura T. Bacteriological evaluation of midecamycin acetate and its metabolites. J Antibiotics (Japan) 1982; 35: 1462–74
- Scaglione F, Falchi M, Cattaneo G. Miocamycin distribution in tonsillar and pulmonary tissues after repeated administration. J Chemother 1990; 2: 220–4